Heparin Market Trends

Growth Drivers

• Growing Pressure of Chronic Diseases on the World - Chronic diseases/Non-communicable diseases are currently the major cause of death among adults in almost all countries. This growing burden of chronic diseases is anticipated to boost the heparin market. As per the National Library of Medicine, every 3 in 5 deaths are attributed to a chronic disease such as cardiovascular disease, lung problem, diabetes, and others.

• Rising Cases of Thromboembolism - In the United States, around 900,000 people are affected by pulmonary embolism or deep vein thrombosis. Moreover, up to 100,000 deaths are caused by venous thromboembolism globally.

• Increase in Number of Cancer Patients - According to the World Health Organization, in 2020, around 2 million new cases of lung cancer and nearly 2.26 million of breast cancer were reported. Moreover, 10 million people died because of cancer.

• Increased Cases of Injury and Deaths by Road Accidents - Fatal and non-fatal road accidents impose a burden of approximately 8 trillion dollars on the world’s economy and globally every day, around 3700 people die in a road accident.

• Higher Instances of Renal Failure- For instance, globally, around 850 million people have acquired some kind of kidney problem.

Challenges

• Side Effects of Heparin in Some Patients - Side effects associated with heparin such as, chest pain, irregular heartbeats, skin discoloration, irregular bleeding, shortness of breath, and others are likely to hamper the growth of the heparin market.
• The dearth of Raw Material Required for the Heparin Formulation
• Higher Cost of Certain Types of Heparin